Long-term morbidity and mortality in patients diagnosed with an insulinoma.
Elina PeltolaPäivi HannulaHeini HuhtalaSaara MetsoJuhani SandJohanna LaukkarinenMirja TiikkainenJukka SirénMinna SoinioPirjo NuutilaLeena MoilanenDavid E LaaksonenTapani EbelingJohanna ArolaCamilla Schalin-JänttiPia JaatinenPublished in: European journal of endocrinology (2021)
The long-term prognosis of patients with a non-metastatic insulinoma is similar to the general population, except for an increased incidence of atrial fibrillation, intestinal obstruction, and possibly breast and kidney cancers. These results need to be confirmed in future studies. Metastatic insulinomas entail a markedly decreased survival.
Keyphrases